Conference
819P Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience
Authors
Lalani A-K; Li H; Heng D; Wood L; Kalirai A; Bjarnason G; Sim H-W; Kollmannsberger CK; Kapoor A; Hotte SJ
Volume
27
Publisher
Elsevier
Publication Date
October 2016
DOI
10.1093/annonc/mdw373.46
Conference proceedings
Annals of Oncology
ISSN
0923-7534